Funded Startups in Ness Ziona
Disclosed round sizes in Ness Ziona cluster tightly around single-digit to tens of millions, but Quantum Source stands out: a $50M Series A on 2024-09-10 i…
Disclosed round sizes in Ness Ziona cluster tightly around single-digit to tens of millions, but Quantum Source stands out: a $50M Series A on 2024-09-10 is the only disclosed round above $35M in the 16 entries (the next-largest disclosed amounts are $35M for VisIC Technologies on 2021-08-25 and $18M for DOT Compliance on 2024-04-15). The period also shows a dense mid-2024 window, with multiple rounds between 2024-02-20 (WeedOut) and 2024-09-25 (Enzymit), while older disclosed rounds span back to 2020-05-20 (Newsight Imaging $7M) and include a 2021 tranche (e.g., INNOVENTRIC $14M on 2021-11-01; VisIC Technologies $35M on 2021-08-25).
Sector and documentation patterns further concentrate: four of the 16 entries are Biotechnology (IBI-Ag 2025-11-16 $4M; BIOMx 2025-02-26 $12M; Enlivex Therapeutics 2024-05-28 $15M; WeedOut 2024-02-20 $8M; plus others labeled similarly), and the data also contains five entries labeled “Series Unknown” (Kadimastem, Eye-Net Mobile, BIOMx, Quantum Art, Quantum Source, Enlivex Therapeutics, etc., with specific examples including Kadimastem on 2025-07-17 $170K and Quantum Art on 2024-08-12 undisclosed). Undisclosed amounts appear in 2 rows (Quantum Art and CardiaCare on 2022-06-07), while the most recent dated entry is IBI-Ag on 2025-11-16.
Most recent rounds
16 shownRelated listings
Frequently asked
Which disclosed round is the largest in this Ness Ziona set, and how far above the rest is it?
Quantum Source’s $50M Series A on 2024-09-10 is the highest disclosed amount in the 16 rows, and it sits clearly above the next-largest disclosed amounts: VisIC Technologies’ $35M on 2021-08-25 and DOT Compliance’s $18M on 2024-04-15.
Do the funding dates cluster in a specific window rather than being evenly spread?
Yes. Several rounds concentrate in 2024, including WeedOut ($8M) on 2024-02-20, Enzymit ($10M) on 2024-09-25, and multiple disclosed rounds in between (e.g., Enlivex Therapeutics $15M on 2024-05-28; DOT Compliance $18M on 2024-04-15). The full span runs from 2020-05-20 (Newsight Imaging $7M) to 2025-11-16 (IBI-Ag $4M).
Are there stage-label gaps or undisclosed amounts that affect comparisons?
There are multiple entries without a stated series: five rows are labeled “Series Unknown” (for example, Kadimastem on 2025-07-17 at $170K and Eye-Net Mobile on 2025-03-11 at $2M). Two rows list “undisclosed” amounts, including Quantum Art on 2024-08-12 and CardiaCare on 2022-06-07.
What stage mix shows up most often among the clearly labeled rounds?
Among labeled stages (excluding the “Series Unknown” and blank row for Newsight Imaging), Series A appears frequently: Enzymit $10M (2024-09-25), IBI-Ag $4M (2025-11-16), Quantum Source $50M (2024-09-10), and WeedOut $8M (2024-02-20). Other labeled stages include Seed (NanoPass Technologies $4M on 2024-07-15), Series B (DOT Compliance $18M on 2024-04-15), Series F (VisIC Technologies $35M on 2021-08-25), and Non-equity Assistance (CardiaCare, amount undisclosed, on 2022-06-07).
Are there outliers that change how the set should be read (sector, size, or both)?
Size is the main outlier dimension: Quantum Source at $50M (2024-09-10) is far above most other disclosed rounds, which include $35M (VisIC Technologies, 2021-08-25) and several in the teens or single digits (e.g., IBI-Ag $4M on 2025-11-16; NanoPass Technologies $4M on 2024-07-15). On the documentation side, the smallest disclosed amount is Kadimastem’s $170K on 2025-07-17, while Quantum Art is an amount-undisclosed outlier at the same time point cluster in 2024 (2024-08-12).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.